Shares of GlaxoSmithKline (NYSE:GSK) saw unusually large options trading activity on Tuesday. Traders bought 34,680 call options on the company, American Banking News.com reports. This is an increase of approximately 1,486% compared to the average volume of 2,187 call options.
GSK has been the subject of a number of recent research reports. Analysts at Barclays reiterated an “equal weight” rating on shares of GlaxoSmithKline in a research note on Friday. Separately, analysts at Citigroup Inc. reiterated a “neutral” rating on shares of GlaxoSmithKline in a research note on Wednesday, February 12th. Finally, analysts at Zacks reiterated a “neutral” rating on shares of GlaxoSmithKline in a research note on Friday, February 7th. They now have a $55.00 price target on the stock. Three research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and four have given a buy rating to the company’s stock. GlaxoSmithKline has a consensus rating of “Hold” and an average price target of $88.67.
GlaxoSmithKline (NYSE:GSK) traded up 1.38% on Tuesday, hitting $56.66. The stock had a trading volume of 3,072,284 shares. GlaxoSmithKline has a 1-year low of $43.68 and a 1-year high of $55.91. The stock has a 50-day moving average of $53.13 and a 200-day moving average of $52.00. The company has a market cap of $135.7 billion and a price-to-earnings ratio of 15.73.
GlaxoSmithKline (NYSE:GSK) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.30 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.30. The company had revenue of $6.91 billion for the quarter, compared to the consensus estimate of $6.84 billion. GlaxoSmithKline’s revenue was up 1.5% compared to the same quarter last year. Analysts expect that GlaxoSmithKline will post $3.72 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Thursday, April 10th. Stockholders of record on Friday, February 21st will be paid a dividend of $0.7496 per share. This represents a $3.00 annualized dividend and a dividend yield of 5.36%. The ex-dividend date is Wednesday, February 19th.
GlaxoSmithKline plc (NYSE:GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.